In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy
Robert L. Bowman(University of Pennsylvania), Ross L. Levine(Memorial Sloan Kettering Cancer Center), Michael Bowman(University of Pennsylvania), Aishwarya Krishnan(Memorial Sloan Kettering Cancer Center), Pablo Sánchez-Vela(Memorial Sloan Kettering Cancer Center), Inés Fernández-Maestre(Memorial Sloan Kettering Cancer Center), Linde A. Miles(Memorial Sloan Kettering Cancer Center), Shoron Mowla(Memorial Sloan Kettering Cancer Center), Martin Carroll(University of Pennsylvania), Michael R. Waarts(Cancer Services), Anthony R. Martinez Benitez(Memorial Sloan Kettering Cancer Center), Laura Bennett(University of Pennsylvania), Sara E. Meyer(Sidney Kimmel Cancer Center), Zachary Zaroogian(Memorial Sloan Kettering Cancer Center), Shira E. Eisman(Memorial Sloan Kettering Cancer Center), Wenbin Xiao(Memorial Sloan Kettering Cancer Center), Andrew Dunbar(Memorial Sloan Kettering Cancer Center), Chad R. Potts(Vanderbilt University Medical Center), Tanmay Mishra(Vellore Institute of Technology University), Nayla Boorady(Memorial Sloan Kettering Cancer Center), Isabelle Csete(Cancer Services), Jennifer J. Trowbridge(Jackson Laboratory), Louise Cai(Memorial Sloan Kettering Cancer Center), Matthew T. Jenkins(Vanderbilt University Medical Center), Sheng F. Cai(Memorial Sloan Kettering Cancer Center), Kavi O’Connor(Memorial Sloan Kettering Cancer Center), Suean Daimia Fontenard(University of Pennsylvania), Young Joo Park(Sutro Biopharma (United States)), Angela Youn(University of Pennsylvania), Matthew Werewski(Memorial Sloan Kettering Cancer Center), P. Brent Ferrell(Vanderbilt University Medical Center), Darren Lee(University of Cincinnati Medical Center), Nisargbhai Shah(Memorial Sloan Kettering Cancer Center)
Cited by 12
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
|Leukemia|2022|3.6k